Join to View Full Profile
UCLA Sch of MedLos Angeles, CA 90001
Dr. Komatsubara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2025
NY State Medical License 2014 - 2019
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 5 citationsSacituzumab govitecan in HRHER2metastatic breast cancer: the randomized phase 3 EVER-132-002 trial.Binghe Xu, Shusen Wang, Min Yan, Joohyuk Sohn, Wei Li
Nature Medicine. 2024-12-01 - 19 citationsA Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal MelanomaAlexander N. Shoushtari, Shaheer Khan, Kimberly M. Komatsubara, Lynn G. Feun, Nicolas Acquavella
Cancers. 2021-11-02 - 88 citationsUpdated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLCJacek Jassem, Filippo de Marinis, Giuseppe Giaccone, A. Vergnenegre, Carlos H. Barrios
Journal of Thoracic Oncology. 2021-07-12
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
